Literature DB >> 20817736

Characterization of leukocyte mono-immunoglobulin-like receptor 7 (LMIR7)/CLM-3 as an activating receptor: its similarities to and differences from LMIR4/CLM-5.

Yutaka Enomoto1, Yoshinori Yamanishi, Kumi Izawa, Ayako Kaitani, Mariko Takahashi, Akie Maehara, Toshihiko Oki, Reiko Takamatsu, Masunori Kajikawa, Toshiyuki Takai, Toshio Kitamura, Jiro Kitaura.   

Abstract

Here we characterize leukocyte mono-Ig-like receptor 7 (LMIR7)/CLM-3 and compare it with an activating receptor, LMIR4/CLM-5, that is a counterpart of an inhibitory receptor LMIR3/CLM-1. LMIR7 shares high homology with LMIR4 in the amino acid sequences of its Ig-like and transmembrane domains. Flow cytometric analysis demonstrated that LMIR4 was predominantly expressed in neutrophils, whereas LMIR7 was highly expressed in mast cells and monocytes/macrophages. Importantly, LMIR7 engagement induced cytokine production in bone marrow-derived mast cells (BMMCs). Although FcRγ deficiency did not affect surface expression levels of LMIR7, it abolished LMIR7-mediated activation of BMMCs. Consistently we found significant interaction of LMIR7-FcRγ, albeit with lower affinity compared with that of LMIR4-FcRγ. Our results showed that LMIR7 transmits an activating signal through interaction with FcRγ. In addition, like LMIR4, LMIR7 synergizes with TLR4 in signaling. Analysis of several chimera receptors composed of LMIR4 and LMIR7 revealed these findings: 1) the transmembrane of LMIR7 with no charged residues maintained its surface expression at high levels in the absence of FcRγ; 2) the extracellular juxtamembrane region of LMIR7 had a negative effect on its surface expression levels; and 3) the strong interaction of LMIR4 with FcRγ depended on the extracellular juxtamembrane region as well as the transmembrane domain of LMIR4. Thus, LMIR7 shares similarities with LMIR4, although they are differentially regulated in their distribution, expression, and function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20817736      PMCID: PMC2975151          DOI: 10.1074/jbc.M110.137166

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

Review 1.  Immune inhibitory receptors.

Authors:  J V Ravetch; L L Lanier
Journal:  Science       Date:  2000-10-06       Impact factor: 47.728

Review 2.  TREMs in the immune system and beyond.

Authors:  Marco Colonna
Journal:  Nat Rev Immunol       Date:  2003-06       Impact factor: 53.106

Review 3.  Regulation of mast-cell and basophil function and survival by IgE.

Authors:  Toshiaki Kawakami; Stephen J Galli
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

4.  An activating and inhibitory signal from an inhibitory receptor LMIR3/CLM-1: LMIR3 augments lipopolysaccharide response through association with FcRgamma in mast cells.

Authors:  Kumi Izawa; Jiro Kitaura; Yoshinori Yamanishi; Takayuki Matsuoka; Ayako Kaitani; Masahiro Sugiuchi; Mariko Takahashi; Akie Maehara; Yutaka Enomoto; Toshihiko Oki; Toshiyuki Takai; Toshio Kitamura
Journal:  J Immunol       Date:  2009-06-26       Impact factor: 5.422

5.  NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.

Authors:  Susan Gilfillan; Emily L Ho; Marina Cella; Wayne M Yokoyama; Marco Colonna
Journal:  Nat Immunol       Date:  2002-11-11       Impact factor: 25.606

6.  DIgR1, a novel membrane receptor of the immunoglobulin gene superfamily, is preferentially expressed by antigen-presenting cells.

Authors:  K Luo; W Zhang; L Sui; N Li; M Zhang; X Ma; L Zhang; X Cao
Journal:  Biochem Biophys Res Commun       Date:  2001-09-14       Impact factor: 3.575

Review 7.  Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family.

Authors:  T Takai; M Ono
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

8.  Analysis of mouse LMIR5/CLM-7 as an activating receptor: differential regulation of LMIR5/CLM-7 in mouse versus human cells.

Authors:  Yoshinori Yamanishi; Jiro Kitaura; Kumi Izawa; Takayuki Matsuoka; Toshihiko Oki; Yang Lu; Fumi Shibata; Satoshi Yamazaki; Hidetoshi Kumagai; Hideaki Nakajima; Mari Maeda-Yamamoto; Victor L J Tybulewicz; Toshiyuki Takai; Toshio Kitamura
Journal:  Blood       Date:  2007-10-10       Impact factor: 22.113

9.  Osteopetrosis and thalamic hypomyelinosis with synaptic degeneration in DAP12-deficient mice.

Authors:  Tomonori Kaifu; Jin Nakahara; Masanori Inui; Kenichi Mishima; Toshihiko Momiyama; Mitsuji Kaji; Akiko Sugahara; Hisami Koito; Azusa Ujike-Asai; Akira Nakamura; Kiyoshi Kanazawa; Kyoko Tan-Takeuchi; Katsunori Iwasaki; Wayne M Yokoyama; Akira Kudo; Michihiro Fujiwara; Hiroaki Asou; Toshiyuki Takai
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

10.  Paired activating and inhibitory immunoglobulin-like receptors, MAIR-I and MAIR-II, regulate mast cell and macrophage activation.

Authors:  Katsumi Yotsumoto; Yasushi Okoshi; Kazuko Shibuya; Satoshi Yamazaki; Satoko Tahara-Hanaoka; Shin-Ichiro Honda; Mitsujiro Osawa; Asato Kuroiwa; Yoichi Matsuda; Daniel G Tenen; Atsushi Iwama; Hiromitsu Nakauchi; Akira Shibuya
Journal:  J Exp Med       Date:  2003-07-21       Impact factor: 14.307

View more
  12 in total

Review 1.  The CD300 molecules: an emerging family of regulators of the immune system.

Authors:  Francisco Borrego
Journal:  Blood       Date:  2013-01-04       Impact factor: 22.113

2.  The CD300e molecule in mice is an immune-activating receptor.

Authors:  Masamichi Isobe; Kumi Izawa; Masahiro Sugiuchi; Tamami Sakanishi; Ayako Kaitani; Ayako Takamori; Akie Maehara; Toshihiro Matsukawa; Mariko Takahashi; Yoshinori Yamanishi; Toshihiko Oki; Shino Uchida; Koichiro Uchida; Tomoaki Ando; Keiko Maeda; Nobuhiro Nakano; Hideo Yagita; Toshiyuki Takai; Hideoki Ogawa; Ko Okumura; Toshio Kitamura; Jiro Kitaura
Journal:  J Biol Chem       Date:  2018-01-22       Impact factor: 5.157

3.  Myelodysplastic syndromes are induced by histone methylation–altering ASXL1 mutations.

Authors:  Daichi Inoue; Jiro Kitaura; Katsuhiro Togami; Koutarou Nishimura; Yutaka Enomoto; Tomoyuki Uchida; Yuki Kagiyama; Kimihito Cojin Kawabata; Fumio Nakahara; Kumi Izawa; Toshihiko Oki; Akie Maehara; Masamichi Isobe; Akiho Tsuchiya; Yuka Harada; Hironori Harada; Takahiro Ochiya; Hiroyuki Aburatani; Hiroshi Kimura; Felicitas Thol; Michael Heuser; Ross L Levine; Omar Abdel-Wahab; Toshio Kitamura
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

4.  MicroRNA-125b-1 accelerates a C-terminal mutant of C/EBPα (C/EBPα-C(m))-induced myeloid leukemia.

Authors:  Yutaka Enomoto; Jiro Kitaura; Masaya Shimanuki; Naoko Kato; Koutarou Nishimura; Mariko Takahashi; Hideki Nakakuma; Toshio Kitamura; Takashi Sonoki
Journal:  Int J Hematol       Date:  2012-07-28       Impact factor: 2.490

5.  Human CD300C delivers an Fc receptor-γ-dependent activating signal in mast cells and monocytes and differs from CD300A in ligand recognition.

Authors:  Mariko Takahashi; Kumi Izawa; Jun-ichi Kashiwakura; Yoshinori Yamanishi; Yutaka Enomoto; Ayako Kaitani; Akie Maehara; Masamichi Isobe; Shinichi Ito; Toshihiro Matsukawa; Fumio Nakahara; Toshihiko Oki; Masunori Kajikawa; Chisei Ra; Yoshimichi Okayama; Toshio Kitamura; Jiro Kitaura
Journal:  J Biol Chem       Date:  2013-01-31       Impact factor: 5.157

6.  Identification and Characterization of CD300H, a New Member of the Human CD300 Immunoreceptor Family.

Authors:  Kouta Niizuma; Satoko Tahara-Hanaoka; Emiko Noguchi; Akira Shibuya
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

7.  Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor.

Authors:  Chigusa Nakahashi-Oda; Satoko Tahara-Hanaoka; Masamichi Shoji; Yasushi Okoshi; Takako Nakano-Yokomizo; Nobuhiro Ohkohchi; Teruhito Yasui; Hitoshi Kikutani; Shin-ichiro Honda; Kazuko Shibuya; Shigekazu Nagata; Akira Shibuya
Journal:  J Exp Med       Date:  2012-07-23       Impact factor: 14.307

8.  Generation and transcriptional programming of intestinal dendritic cells: essential role of retinoic acid.

Authors:  R Zeng; M Bscheider; K Lahl; M Lee; E C Butcher
Journal:  Mucosal Immunol       Date:  2015-07-01       Impact factor: 7.313

9.  Leukocyte mono-immunoglobulin-like receptor 8 (LMIR8)/CLM-6 is an FcRγ-coupled receptor selectively expressed in mouse tissue plasmacytoid dendritic cells.

Authors:  Ayako Kaitani; Kumi Izawa; Akie Maehara; Masamichi Isobe; Ayako Takamori; Toshihiro Matsukawa; Mariko Takahashi; Yoshinori Yamanishi; Toshihiko Oki; Hiromichi Yamada; Masakazu Nagamine; Shino Uchida; Koichiro Uchida; Tomoaki Ando; Keiko Maeda; Nobuhiro Nakano; Toshiaki Shimizu; Toshiyuki Takai; Hideoki Ogawa; Ko Okumura; Toshio Kitamura; Jiro Kitaura
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

10.  SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS.

Authors:  D Inoue; J Kitaura; H Matsui; H-A Hou; W-C Chou; A Nagamachi; K C Kawabata; K Togami; R Nagase; S Horikawa; M Saika; J-B Micol; Y Hayashi; Y Harada; H Harada; T Inaba; H-F Tien; O Abdel-Wahab; T Kitamura
Journal:  Leukemia       Date:  2014-10-13       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.